National Institutes of Health

Description

The purpose of this funding opportunity announcement (FOA) is to accelerate the development and validation of sample sparing assays that can be applied for studying the human immune system in health and disease.Development of sample sparing assays will lead to maximum use of the sampled material by significant reduction of sample volumes/amounts required or by simultaneous multi-parameter assessments of immune function.By expanding the spectrum of parameters that can be measured on small samples derived from human subjects, assays developed in response to this announcement will be valuable for advancing our fundamental understanding of the immune system and equally important for immune monitoring in healthy as well as disease conditions such as allergy, asthma, autoimmunity, acquired and primary immunodeficiency, transplantation, and infection.New sample sparing assays will have a major impact on clinical studies aimed to understand immune functions in young children with infectious diseases and/or immune mediated disorders; for example, food allergy, diabetes or primary immunodeficiency where sample availability is most limited.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV